NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Total Liabilities (Quarterly): 20.23M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.23M |
| September 30, 2023 | 22.34M |
| June 30, 2023 | 28.42M |
| March 31, 2023 | 37.90M |
| December 31, 2022 | 47.84M |
| September 30, 2022 | 49.98M |
| June 30, 2022 | 45.29M |
| March 31, 2022 | 48.64M |
| December 31, 2021 | 66.74M |
| September 30, 2021 | 61.82M |
| June 30, 2021 | 49.94M |
| March 31, 2021 | 45.96M |
| Date | Value |
|---|---|
| December 31, 2020 | 49.00M |
| September 30, 2020 | 49.38M |
| June 30, 2020 | 46.12M |
| March 31, 2020 | 41.73M |
| December 31, 2019 | 49.68M |
| September 30, 2019 | 51.43M |
| June 30, 2019 | 50.57M |
| March 31, 2019 | 350.80M |
| December 31, 2018 | 354.28M |
| June 30, 2018 | 361.01M |
| December 31, 2017 | 369.92M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
20.23M
Minimum
Dec 2023
66.74M
Maximum
Dec 2021
45.42M
Average
48.64M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Catalent Inc | 6.268B |
| AIM ImmunoTech Inc | 11.36M |
| Perspective Therapeutics Inc | 48.40M |
| Protalix BioTherapeutics Inc | 60.04M |
| Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 168.87M |
| Shareholders Equity (Quarterly) | 148.64M |
| Current Ratio | 7.791 |